Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 23, 2022
Mon, August 22, 2022
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
Jonathan Chang Maintained (BCYC) at Buy with Increased Target to $50 on, Aug 22nd, 2022
Jonathan Chang of SVB Leerink, Maintained "Bicycle Therapeutics plc" (BCYC) at Buy with Increased Target from $48 to $50 on, Aug 22nd, 2022.
Jonathan has made no other calls on BCYC in the last 4 months.
There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 0 agree with Jonathan's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Jonathan
- Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $57 on, Friday, August 5th, 2022
- Peter Lawson of "Barclays" Initiated at Buy and Held Target at $30 on, Thursday, July 28th, 2022
- William Maughan of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $60 on, Wednesday, July 6th, 2022
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $37 on, Monday, May 23rd, 2022
